Mirae Asset Global Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Mirae Asset Global Investments’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,000	Closed	-$2.89M	–	1630
2025 Q4	$2.89M	Buy	+14,000	New	+$2.8M	0.01%	701
2015 Q4	–	Sell	-12,100	Closed	-$1.23M	–	464
2015 Q3	$1.23M	Buy	12,100 +6,600	+120%	+$785K	0.05%	268
2015 Q2	$682K	Buy	5,500 +1,000	+22%	+$121K	0.02%	354
2015 Q1	$532K	Buy	+4,500	New	+$509K	0.02%	367

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Mirae Asset Global Investments's FBT Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 14,000 shares — an estimated $2.89M sold.

Mirae Asset Global Investments first reported a position in FBT in Q1 2015 and held it in 4 quarters. The position peaked at $2.89M in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Mirae Asset Global Investments reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
Mirae Asset Global Investments sold 14,000 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.89M.
Mirae Asset Global Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 4 quarters.
Mirae Asset Global Investments's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.89M in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.